|Bid||552.88 x 800|
|Ask||567.89 x 1000|
|Day's Range||549.75 - 560.25|
|52 Week Range||305.63 - 579.00|
|Beta (5Y Monthly)||0.74|
|PE Ratio (TTM)||106.92|
|Earnings Date||Oct 25, 2021 - Oct 29, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||522.55|
DexCom (DXCM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Analyst Blog Highlights: Edwards Lifesciences, DexCom, Twitter, Cigna Corp and Restaurant Brands
Today's Research Daily features new research reports on 12 major stocks, including Edwards Lifesciences Corporation (EW), DexCom, Inc. (DXCM), and Twitter, Inc. (TWTR).